Objectives To assess whether clinical decision support, using computerized sexually transmitted infection (STI) risk assessments, results in increased STI testing of adolescents at high risk for STI.
Conclusions Providing sexual health survey-derived decision support to emergency department clinicians led to increased testing rates for STI in adolescents at high risk for infection, particularly in those presenting asymptomatic for infection. Studies to understand potential barriers to decision support adherence should be undertaken to inform larger, multicenter studies that could determine the generalizability of these findings and whether this process leads to increased STI detection. 
Trial registration ClinicalTrials.gov: NCT02509572.
A dolescents are affected disproportionately by sexually transmitted infections (STIs). [1] [2] [3] [4] [5] Of the 19 million new cases of STIs in the US each year, more than 9 million occur among adolescents. 5 The emergency department (ED) is a key point of access to care for many adolescents, because they account for 15.8% of all ED visits, or almost 15 million ED visits annually. [6] [7] [8] [9] More than one-third of adolescents do not report a source of primary care, [10] [11] [12] [13] and fewer than 15% of adolescents participate in annual routine health maintenance examinations.
14 Furthermore, adolescents who seek care at EDs engage in riskier behaviors than those who access primary care services. 12, 15 The early diagnosis and treatment of STIs can prevent serious reproductive morbidity and mortality, including pelvic inflammatory disease, ectopic pregnancy, infertility, and facilitation of transmission of HIV. Considering that one of the goals of Healthy People 2020 is increased STI screening for youth, 16 the ED may serve as a strategic setting for the diagnosis and treatment of STIs, and may in fact be the only site where this vulnerable population encounters health care providers.
STI testing is not conducted routinely in the ED setting. [17] [18] [19] Even when patients present with STI-related symptoms, sexual histories are not obtained routinely by clinicians, 17, [19] [20] [21] and STI testing is not always conducted, [18] [19] [20] 22 leading to underdiagnosis and undertreatment. Although adolescents are interested in receiving sexual health education and treatment in the ED setting, 23, 24 adolescent patients may be uncomfortable disclosing sensitive health information to clinicians in face-to-face interviews. [25] [26] [27] [28] [29] [30] Furthermore, patients may not recognize that their symptoms may be related to an STI or that they are at risk for STIs and, therefore, may not disclose their sexual behavior unless prompted. Finally, the hectic pace and lack of privacy in the ED setting may make it difficult to provide sexual health care confidentially and efficiently.
To address these barriers, computerized screening may serve as an additional method to obtain sensitive information efficiently and accurately. 29, [31] [32] [33] [34] Previously, we developed the sexual health screen, a computerized survey to efficiently and confidentially identify adolescents at risk for STIs. 35 The purpose of this study was to conduct a randomized behavioral trial to evaluate the effectiveness of decision support derived from the sexual health screen for targeted STI testing among adolescents at high risk for STIs. We hypothesized that provision of decision support for targeted testing of adolescents assessed to be at high risk for STIs would result in significantly increased frequency of STI testing compared with usual care (ie, nonreceipt of the decision support).
Methods
We performed a single-blind, 2-arm, randomized, controlled trial (ClinicalTrials.gov: NCT02509572) to determine whether provision of decision support based on the sexual health screen resulted in increased STI testing of adolescents at high risk for STIs. Although trial registration was not required for this study, it was registered retrospectively on July 21, 2015, after all of the patients were enrolled, for the public record. Based on our prior work demonstrating differences in STI testing by gender and presence or absence of STI-related symptoms, 36 we purposefully oversampled females and asymptomatic patients. We ensured balanced allocation within groups by age, gender, and presence of STI-related symptoms in a 1:1. The randomization sequence was created by DatStat Illume (Seattle, Washington), which hosted our computerized sexual health survey, using random permuted blocks, ranging in size from 2 to 6. The hospital's Institutional Review Board approved the study protocol with a waiver of parental consent because adolescents are allowed to seek and receive confidential sexual health services in our jurisdiction.
Study Setting and Population
The study was conducted at a single, urban, pediatric ED located in a free-standing tertiary care, pediatric academic center with an annual ED visit volume of approximately 90 000, within a city with the highest rate of STIs nationally. 37 During the study period, trained research staff approached patients aged 14-19 years for study participation during randomly selected 8-hour shifts from 7 a.m.-11 p.m. daily. Because informed consent was required, we excluded patients who were critically ill, developmentally or neurocognitively delayed, in police custody, or presenting with altered mental status, a psychiatric emergency, or after an acute sexual assault. Because the survey was only available in English, patients who were not literate or did not understand English were ineligible. We also excluded patients from participation if they were under the clinical care of any of the study investigators.
Screening Tool
All enrolled patients completed the computerized sexual health screen, a validated sexual risk assessment tool. 35 This survey was administered via a tablet-based computer with headphones provided for patients in an audio computer-assisted self-interview format. Based on participant survey responses, subjects were classified into 1 of 3 categories for STI risk. Subjects were classified as at high risk for STIs if they disclosed being sexually active and having either the presence of STIrelated symptoms or any of the following high-risk behaviors: more than 1 sexual partner in the last 3 months, no condom use during last sex, or a prior history of STI. Subjects were classified as at risk if they disclosed being sexually active but did not disclose having any STI-related symptoms or any high-risk sexual behaviors. Subjects were classified as at low risk if they denied any history of sexual activity.
Intervention
For subjects randomized to the intervention arm, the attending physician received decision support, that is, a printed report that included recommendations for gonorrhea and chlamydia testing based on the risk category derived from the sexual health screen. When patients were classified as at high risk, the attending physician received recommendations that STI testing was "highly recommended" and when they cared for patients who were classified as at risk, STI testing was "recommended." When attending physicians cared for patients who were classified as at low risk, they received recommendations that STI testing "was not necessary at this time." For patients in the usual care arm, the attending physician received no decision support.
All study participants, including participants who screened at low risk, underwent STI testing for Neisseria gonorrhoeae and Chlamydia trachomatis via polymerase chain reaction (Abbott RealTime PCR; Abbott Park, Illinois). We did not include HIV testing or Trichomonas testing specifically as study outcomes because our institution already has a well-established opt-out HIV screening program and because there are no current recommendations for Trichomonas testing of asymptomatic individuals. 38 If study participants did not have STI testing ordered by the clinician, research assistants sent previously collected urine for STI testing at time of ED discharge under the research protocol. As part of the sexual health screen, confidential phone numbers for result notification were collected from all enrolled patients. All patients with a positive test were notified of the results and prescribed or referred for treatment, either by clinical staff or the principal investigator.
Measures
The primary outcome measures were the difference in STI testing frequencies between the intervention and usual care arms for the entire cohort as well as for the asymptomatic participants who screened at high risk for STIs. We chose to focus on this asymptomatic population because we believe this group would be most likely to benefit most from improvements in screening, as they represent a group of patients who may not otherwise be identified. We chose STI testing as our primary outcome because the most proximate outcome for clinical decision support is clinician decision to perform STI testing. We hypothesized that STI testing rates would be higher in the intervention arm compared with the usual care arm. With a baseline STI testing rate of 10% 36 and at an alpha of 0.05, a sample size of 600 would provide 90% power to detect a 10% absolute difference between the 2 arms. To address potential perceived barriers to future implementation, as a secondary measure, we determined whether study participation or THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 183 randomization to the intervention group resulted in increased length of stay in the ED.
Data Analyses
We calculated the difference in STI testing frequency among patients at high risk for STIs assigned to the decision support intervention arm compared with the non-decision support/ usual care arm. We also performed logistic regression to estimate difference in effect size between the intervention and usual care arms after adjustment for potential confounding variables, including age, gender, race/ethnicity, and insurance status. We derived estimates from our models and included ORs and risk differences with 95% CI, using an alpha of 0.05 for statistical significance. We used the Mann-WhitneyWilcoxon test to compare differences in median ED duration of stay between patients who enrolled and declined participation and between the intervention and usual care arms. We used Stata 12.0 (StataCorp, College Station, Texas) for all analyses.
Results
We approached 1075 eligible patients between October 2014 and July 2015, and 720 (67.0%) consented. The most commonly reported reasons for declining were uninterested (42.8%), not feeling well (11%), and did not want to/unable to provide a urine sample (6.2%). There were no demographic differences between patients who agreed to or declined study participation. Of the 720 enrolled, 367 were randomized to the intervention arm and 353 to the usual care arm, of which 323 and 312, respectively, had evaluable data (Figure; available at www.jpeds.com). The mean age of participants was 16.2 years and the majority was female, of nonHispanic black race/ethnicity, and had public insurance. Sixty percent of enrolled patients denied being sexually experienced (classified as at low risk for STIs) and 33% reported engaging in high-risk sexual behavior (classified as at high risk for STIs). There were no differences between the intervention and usual care groups with respect to demographics or sexual experience (Table I) .
Among the 211 patients who were classified at high risk on the sexual health screen within the entire cohort, 52.3% (58/ 111) in the intervention arm and 42.0% (42/100) (Table II) .
From the final sample of 635 participants, STI prevalence was 5.5% (95% CI 3.7-7.3). STI prevalence increased with higher risk levels (P < .001). Participants classified as at low risk had an STI prevalence of 1.3% (95% CI 0.2-2.5). Participants classified as at risk had an STI prevalence of 2.2% (95% CI −2.2 to 6.5). Participants classified as at high risk had an STI prevalence of 13.7% (95% CI 9.1-18.4). Twenty of these patients (69%) underwent clinician-ordered STI testing: 11 of 15 (73.3%) in the intervention group compared with 9 of 14 (64.3%) in the usual care group.
There was no difference in median ED duration of stay between eligible patients who enrolled and declined study participation (234 minutes vs 222 minutes; P = .2). Additionally, there was no difference in median ED duration of stay between Table I . Demographics of study population All (n = 635), n (%) Intervention (n = 367), n (%) Usual care (n = 353), n (%) enrolled patients assigned to the intervention and usual care arms (234.0 minutes vs 234.5 minutes; P = .4).
Discussion
In this randomized behavioral trial, we found that provision of decision support through the use of a computerized sexual health screen for risk of STIs led to increased STI testing. These effects were more striking in those who were asymptomatic for STIs. Participants asymptomatic for STIs who screened at high risk for STIs and whose physicians received decision support, had almost 5 times the odds of undergoing STI testing compared with participants in the usual care arm. These findings suggest that the use of a standardized, self-administered, computerized sexual health screen was effective in guiding clinicians to perform targeted STI testing for adolescents at high risk for STIs. This effect occurred without increasing ED duration of stay. Although high rates of STIs have been found among adolescents seeking care in an ED, 39-42 STI screening is not performed universally in this setting. This may be due in part to the fact that the ED is not viewed traditionally as a venue for public health interventions and prevention. However, the notion that the ED may serve as a safety net for vulnerable populations has gained attention recently, and screening for highrisk conditions such as HIV, 43 intimate partner violence, 44 and suicidality, 45 is becoming practiced more widely. 46 Both existing research and expert consensus support the need for research addressing the effectiveness, sustainability, and integration of ED-based STI screening programs. 47, 48 Although the Centers for Disease Control and Prevention recommend universal screening for HIV in EDs, 43 currently there are no recommendations for ED-based STI screening. To overcome barriers to performing STI screening in the ED setting, we previously developed a computerized sexual health assessment tool to identify efficiently and confidentially adolescents at risk for STIs. 35 The difference in clinician-ordered STI testing frequency between the intervention and usual care arms highlights the efficacy of this self-administered assessment tool to provide decision support to clinicians. Our results support the findings of a prior study that used an interrupted time-series design to assess differences in STI testing rates before and after the introduction of decision support. 49 However, the prior study was not a randomized behavioral trial and, therefore, unable to control for temporal trends.
The greatest impact of the clinical decision support, which led to increased STI testing among asymptomatic patients, likely was because this population of patients would otherwise not have been tested during routine clinical care. Alternatively, when patients seek care in an ED owing to STI-related symptoms, clinicians may be more likely to obtain sexual histories or order STI testing without obtaining a sexual history, and thus not require decision support. In our study, asymptomatic patients classified at high risk for STIs whose attending physicians received decision support had almost 5 times the odds of being tested for STIs compared with the usual care arm. Our data suggest that, through the sexual health screen-derived decision support process, many more youth may have the opportunity to be diagnosed and treated for an STI compared with those in usual practice.
Although not our primary outcome, we found higher rates of clinician-detected STIs among patients assigned to the intervention arm compared with the usual care arm. To conduct a study testing for statistically significant differences in STI detection rates properly, a sample size of more than 10 000 subjects would be required. However, the results of our study highlight the potential impact of this tool in the downstream detection of STIs, treatment, and prevention interventions, ultimately contributing to a decrease in adolescent STI rates and prevention of morbidity from untreated infection.
The findings from this study should be considered in light of potential limitations. Despite demonstrating increased STI testing frequency among patients who were cared for by clinicians receiving decision support, screening recommendations were followed in only one-half of the visits. Lack of 100% adherence to recommendations may have been affected by delivery process of the decision support, which was provided in the context of a randomized, controlled trial, rather than a quality improvement initiative. In a systematic review designed to understand decision support system features most important for improving clinical practice, features identified included integration with the electronic order entry system, request for documentation of reason for not following system recommendations, and provision of the decision support at the time and location of decision making. 50 In our study, although study participants completed the sexual health screen via a computerized tablet, the decision support was provided to clinicians via a printed report rather than being integrated into the electronic health record; therefore, the process did not prompt electronic orders or ask for reasons for foregoing STI testing. In addition, clinicians may have been provided the decision support while they were busy with other patients and, thus, the decision support was not optimized for ED workflow. Furthermore, we implemented this process without any of the usual support measures provided in typical implementation or quality improvement studies, such as clinician education, a campaign to continuously remind clinicians of the intervention, coaching and support to reduce barriers, and audit and feedback to monitor clinician performance. Although we were unable to incorporate all these features in our pilot study, if these features were incorporated into a subsequent iteration of our sexual health screenderived decision support, we may see an even greater effect size and impact of the decision support on STI testing. This study was conducted at a single, urban pediatric ED located in a city with the highest rates of C trachomatis nationally, and participants largely were publicly insured minority youth. Although the sample may not be generalizable to other populations, this represents an important target for STI prevention and intervention. Additionally, although this study was designed to overcome ED-related barriers to STI screening, many of these barriers also may be applicable to other clinical settings, including primary care. Furthermore, as a single-center pilot study, although we demonstrated a large effect size of our intervention, its wide confidence intervals reflect the small sample size of our cohort. Finally, although there were no demographic differences between participants and those who declined participation, there may be selection bias with unaccounted differences between those enrolled and our overall ED population.
The ease of administration, efficient nature of obtaining sensitive information, and efficacy in identifying high-risk patients make the sexual health screen a highly useful tool in the ED for STI screening. Implementation of targeted STI screening strategies, such as the one studied, have the potential to decrease the societal burden of adolescent STIs and prevent morbidity associated with untreated infection. Future studies should include larger, multicenter effectiveness trials to evaluate generalizability, addition of other features of decision support to optimize uptake of this process, and to determine if this process ultimately results in increased STI detection. ■ 
